Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial

Elias Jabbour, Guillaume Richard-Carpentier, Yuya Sasaki, Marina Konopleva, Keyur Patel, Kathryn Roberts, Zhaohui Gu, Feng Wang, Xuelin Huang, Koji Sasaki, Nicholas J. Short, Nitin Jain, Farhad Ravandi, Naval G. Daver, Tapan M. Kadia, Yesid Alvarado, Courtney D. DiNardo, Ghayas C. Issa, Naveen Pemmaraju, Guillermo Garcia-ManeroSrdan Verstovsek, Sa Wang, Joseph D. Khoury, Jeffrey Jorgensen, Richard Champlin, Issa Khouri, Partow Kebriaei, Heather Schroeder, Maria Khouri, Charles G. Mullighan, Koichi Takahashi, Susan M. O'Brien, Hagop Kantarjian

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences